Safety and immune response study of GC3111B vaccine in healthy adults
Part of Immune system & allergy clinical trials.
This trial tests a new vaccine called GC3111B to see if it is safe and helps the body build protection against diphtheria, tetanus, and pertussis (whooping cough). It is for healthy adults who have not had a similar vaccine in the last 2 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 64 years old.
- You have not had a diphtheria, tetanus, or pertussis vaccine in the last 2 years.
- You have not received any vaccine in the last 4 weeks.
- You have never had a Tdap vaccine before.
- You are not pregnant or breastfeeding.
- You have not taken part in another clinical trial in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a reduced-dose vaccine that protects against diphtheria, tetanus, and whooping cough (pertussis). It is designed for people 6 years and older who have not recently received other vaccines and are generally healthy.
This trial tests a new combination vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and helps the body build immunity.
This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.
This trial tests a new vaccine that protects against diphtheria, tetanus, and pertussis (whooping cough). It is for healthy infants who are about 2 months old and live permanently in the area. The goal is to see if the vaccine is safe and works well.
This study tests a vaccine that protects against three diseases—diphtheria, tetanus, and whooping cough—given during pregnancy. Researchers want to see if the vaccine is safe for pregnant women and their babies, and whether it helps protect newborns.
This study is checking how long the protection from an earlier vaccine (which combined protection against whooping cough, diphtheria, and tetanus) lasts. If you took part in that earlier trial, this follow-up will help see if you still have protection.
Hear when a new Tetanus-diphtheria-acellular Pertussis (Tdap) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.